Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Airsculpt Technologies, Inc. (AIRS – Research Report), Vir Biotechnology (VIR – Research Report) and Gilead Sciences (GILD – Research Report).
Airsculpt Technologies, Inc. (AIRS)
In a report issued on November 15, Whit Mayo from Leerink Partners reiterated a Buy rating on Airsculpt Technologies, Inc., with a price target of $7.75. The company’s shares closed last Friday at $4.94.
According to TipRanks.com, Mayo is a 3-star analyst with an average return of
Airsculpt Technologies, Inc. has an analyst consensus of Moderate Buy, with a price target consensus of $6.88.
See Insiders’ Hot Stocks on TipRanks >>
Vir Biotechnology (VIR)
In a report issued on November 16, Roanna Ruiz from Leerink Partners maintained a Buy rating on Vir Biotechnology, with a price target of $24.00. The company’s shares closed last Friday at $9.69, close to its 52-week low of $7.72.
According to TipRanks.com, Ruiz is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Vir Biotechnology with a $32.86 average price target, implying a 235.3% upside from current levels. In a report issued on November 2, Goldman Sachs also maintained a Buy rating on the stock with a $28.00 price target.
Gilead Sciences (GILD)
In a report issued on November 17, Daina Graybosch from Leerink Partners reiterated a Hold rating on Gilead Sciences, with a price target of $87.00. The company’s shares closed last Friday at $75.45, close to its 52-week low of $72.87.
According to TipRanks.com, Graybosch has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Gilead Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $89.71, which is a 19.8% upside from current levels. In a report issued on November 8, Deutsche Bank also initiated coverage with a Hold rating on the stock with a $75.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AIRS:
- Options Volatility and Implied Earnings Moves Today, November 10, 2023
- AirSculpt Technologies backs FY23 revenue view $196M, consensus $193.14M
- AirSculpt Technologies reports Q3 adjusted EPS 5c, consensus (2c)
- AirSculpt Technologies Announces Third Quarter 2023 Results and Reaffirms 2023 Guidance
- AIRS Upcoming Earnings Report: What to Expect?
